The specific enhancement of CHRNA2 expression in females suggests that estrogen or other sex-specific factors may enhance the expression or functional activity of these receptors in response to the physiological stresses imposed by AOM/DSS treatment. This evidence concerns the gene CHRNA2 and infectious otitis media.